As of Oct 21, Biotech company PerturbAI announced a collaboration with OpenAI and Scripps Research on an AI reasoning framework that runs thousands of agents in parallel to analyze lab data, search the scientific literature and propose testable hypotheses, 36Kr reports, citing Jiemian.
Not confirmed by the company — reported on Oct 21, 2026 (source: 36kr.com).
Biotech company PerturbAI announced a collaboration with OpenAI and Scripps Research on an AI reasoning framework that runs thousands of agents in parallel to analyze lab data, search the scientific literature and propose testable hypotheses, 36Kr reports, citing Jiemian. The partners plan to explore new drug targets.
Items older than 72 hours never go in Top stories and show their original date.